• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Jack Buzby, USA

    Jack Buzby, USA

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Mark Miller, UK

    Mark Miller, UK

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Frank Taylor, USA

    Frank Taylor, USA

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Paul Launer, USA

    Paul Launer, USA

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Daniel Hare, USA

    Daniel Hare, USA

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Jason Goodman, USA

    Jason Goodman, USA

  • Olga, Argentina

    Olga, Argentina

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Phil Rossall, UK

    Phil Rossall, UK

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Lombana, Spain

    Lombana, Spain

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Willi Klein, UK

    Willi Klein, UK

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login